Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:03 AM
Ignite Modification Date:
2025-12-25 @ 4:03 AM
NCT ID:
NCT06794502
Eligibility Criteria:
Inclusion Criteria:
* Pulmonary TB patients were positive based on the results of the Rapid Molecular Test GeneXpert M. tuberculosis (MTB)/Rifampicin (RIF),
* Patients who were undergoing the initiation phase of anti-TB treatment for the first time,
* Non-Multi Drug Resistant (MDR)/Extensively-Drug Resistant (XDR) TB patients with first-line anti-TB treatment (rifampicin, isoniazid, pyrazinamide, and ethambutol),
* Patients \>18 years old,
* Patients who were willing to become research subjects and signed informed consent.
Exclusion Criteria:
* TB patients with Human Immunodeficiency Virus (HIV) positive,
* Patients who did not complete the study,
* Patients with non-compliance in taking medication,
* Patients with comorbidities (autoimmune and cancer),
* Smoking patients,
* Patients contraindicated in using butterfly pea flower extract.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
69 Years
Study:
NCT06794502
Study Brief:
Protocol Section:
NCT06794502